1. Home
  2. VKTX vs MEOH Comparison

VKTX vs MEOH Comparison

Compare VKTX & MEOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • MEOH
  • Stock Information
  • Founded
  • VKTX 2012
  • MEOH 1968
  • Country
  • VKTX United States
  • MEOH Canada
  • Employees
  • VKTX N/A
  • MEOH N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • MEOH Major Chemicals
  • Sector
  • VKTX Health Care
  • MEOH Industrials
  • Exchange
  • VKTX Nasdaq
  • MEOH Nasdaq
  • Market Cap
  • VKTX 3.4B
  • MEOH 3.1B
  • IPO Year
  • VKTX 2015
  • MEOH N/A
  • Fundamental
  • Price
  • VKTX $34.07
  • MEOH $44.25
  • Analyst Decision
  • VKTX Strong Buy
  • MEOH Buy
  • Analyst Count
  • VKTX 14
  • MEOH 7
  • Target Price
  • VKTX $97.29
  • MEOH $62.57
  • AVG Volume (30 Days)
  • VKTX 4.8M
  • MEOH 429.6K
  • Earning Date
  • VKTX 02-05-2025
  • MEOH 01-29-2025
  • Dividend Yield
  • VKTX N/A
  • MEOH 1.62%
  • EPS Growth
  • VKTX N/A
  • MEOH N/A
  • EPS
  • VKTX N/A
  • MEOH 2.39
  • Revenue
  • VKTX N/A
  • MEOH $3,719,829,000.00
  • Revenue This Year
  • VKTX N/A
  • MEOH $17.72
  • Revenue Next Year
  • VKTX $986.87
  • MEOH $6.30
  • P/E Ratio
  • VKTX N/A
  • MEOH $19.14
  • Revenue Growth
  • VKTX N/A
  • MEOH N/A
  • 52 Week Low
  • VKTX $28.64
  • MEOH $36.13
  • 52 Week High
  • VKTX $99.41
  • MEOH $56.43
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 51.41
  • MEOH 31.00
  • Support Level
  • VKTX $28.90
  • MEOH $50.48
  • Resistance Level
  • VKTX $34.37
  • MEOH $54.49
  • Average True Range (ATR)
  • VKTX 2.37
  • MEOH 1.52
  • MACD
  • VKTX 0.66
  • MEOH -0.73
  • Stochastic Oscillator
  • VKTX 70.06
  • MEOH 0.39

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About MEOH Methanex Corporation

Methanex Corp manufactures and sells methanol. Methanex's customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. Methanex distributes its products through a global supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. China generates the most revenue of any geographical segment.

Share on Social Networks: